Research output per year
Research output per year
Personal profile
Fingerprint
Dive into the research topics where Sebastien Malinge is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Menin inhibitors display differential in vitro sensitivity in KMT2A-rearranged infant acute lymphoblastic leukemia
Dymock, S. C. C., Oommen, J., Malinge, S., Cheung, L. C. & Kotecha, R. S., 2026, In: Leukemia and Lymphoma.Research output: Contribution to journal › Letter › peer-review
-
Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destruction
Kuek, V., Oommen, J., Ferrari, E., Yuan, J., Economides, A. N., Lock, R. B., Malinge, S., Kotecha, R. S. & Cheung, L. C., Apr 2026, In: HemaSphere. 10, 4, e70355.Research output: Contribution to journal › Letter › peer-review
Open Access -
Perspectives on the origin and therapeutic opportunities in Down syndrome-associated leukemia
Panchal, K., Armitage, J., Cheung, L. C., Kotecha, R. S. & Malinge, S., 18 Sept 2025, (E-pub ahead of print) In: Cancer and Metastasis Reviews. 44, 4, 17 p., 70.Research output: Contribution to journal › Review article › peer-review
1 Link opens in a new tab Citation (Scopus) -
Preclinical Assessment of Dactinomycin in KMT2A-Rearranged Infant Acute Lymphoblastic Leukemia
Chiu, S. K., Ferrari, E., Oommen, J., Malinge, S., Cheung, L. C. & Kotecha, R. S., 1 Feb 2025, In: Cancers. 17, 3, 12 p., 527.Research output: Contribution to journal › Article › peer-review
Open Access2 Link opens in a new tab Citations (Web of Science) -
Targeting osteoclasts for treatment of high-risk B-cell acute lymphoblastic leukemia
Kotecha, R. S., Trinder, S. M., Hughes, A. M., Mullin, B. H., Rashid, S., Yuan, J., Xu, J., Duncan, O., Skut, P., Chua, G. A., Singh, S., Oommen, J., Lock, R. B., Kees, U. R., Malinge, S., Kuek, V. & Cheung, L. C., Dec 2025, In: Blood Cancer Journal. 15, 1, 5 p., 25.Research output: Contribution to journal › Letter › peer-review
Open Access3 Link opens in a new tab Citations (Scopus)
-
Enhancing natural killer cell function to combat high-risk B-ALL with Tri-specific Killer Engagers (TriKEs)
Foley, B. (Investigator 01), Armitage, J. (Investigator 02), Malinge, S. (Investigator 03) & Waithman, J. (Investigator 04)
1/01/25 → 30/09/26
Project: Research
-
Paediatric Cancer Immunotherapy for Australia
Lesterhuis, W. (Investigator 01), Gottardo, N. (Investigator 02), Endersby, R. (Investigator 03), Kotecha, R. (Investigator 04), Cheung, L. (Investigator 05), Malinge, S. (Investigator 06), McDonnell, A. (Investigator 07) & Elaskalani, O. (Investigator 08)
Australian Lions Childhood Cancer Research Foundation (ALCCRF)
1/07/23 → 30/06/25
Project: Research
-
Towards developing novel targeted therapies for Down syndrome leukemia
Malinge, S. (Investigator 01)
1/07/23 → 30/06/25
Project: Research
-
Towards preventing relapse in childhood leukaemia
Malinge, S. (Investigator 01), Aya-Bonilla, C. (Investigator 02) & Anderson, D. (Investigator 03)
1/01/22 → 31/12/22
Project: Research
-
Targeting the treatment-resistant cells to prevent relapse in childhood leukaemia
Malinge, S. (Investigator 01)
1/01/20 → 31/12/23
Project: Research